Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Ana Bouchet

CEO

Lifesome Therapeutics

MADRID, Spain

3 profile visits

I am Ana Bouchet, co-founder of Lifesome Therapeutics. I am an international expert in nanoparticle formulation, lipid biophysics and encapsulation processes. At Lifesome, I manage the production of the first antitumoral lipid nanoparticle in the market.

My organisation

Lifesome Therapeutics S.L. is a spanish company who produces the first "smart lipid nanoparticles" in the market. Whereas other lipid nanoparticles are passive carriers, our nanoparticles have intrinsic biologic activity which enhances the antitumoral and antibiotic potential of encapsulated drugs. By doing so, we provide our clients with strong formulations that ease their progress from the lab bench to successful preclinical trials.
Read more

About me

Dr Ana Bouchet investigated the lipid-associated dysregulation of ion channels in cancer and metastasis development at the University of Tours (France), funded by the Prestige Marie Curie Fellowship Program. She pursued Innovation Managing studies at IESE Business School (Madrid, Spain) and in 2021 she led Lifesome Therapeutics’ acceleration program (CATAPULL).

Social media

Marketplace (1)